Published in Ther Drug Monit on April 01, 2001
Trough levels of tacrolimus. Ther Drug Monit (2002) 0.82
Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation. Eur J Clin Pharmacol (2011) 0.78
The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients. J Pharm (Cairo) (2014) 0.77
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer (2000) 4.70
Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. Am J Transplant (2015) 2.71
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol (1999) 2.67
Letter: Creatinine clearance: bedside estimate. Ann Intern Med (1973) 2.52
An improved method of digoxin therapy. Ann Intern Med (1968) 2.19
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide. Antimicrob Agents Chemother (1997) 2.13
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant (2011) 1.75
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology (1997) 1.74
Estimation of creatinine clearance when urine cannot be collected. Lancet (1971) 1.61
Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol (1997) 1.45
The role of radiotherapy in the conservative treatment of rectal carcinoma--the Lyon experience. Acta Oncol (1998) 1.39
[Delayed colo-anal anastomosis after laparoscopic proctectomy with total mesorectal resection for rectal cancer]. J Chir (Paris) (2008) 1.39
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38
[Accidental intravenous injection of potassium chloride: analysis of contributing factors and barriers to risk reduction]. Ann Fr Anesth Reanim (2009) 1.38
A nomogram for digoxin therapy. Am J Med (1974) 1.38
Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr (2001) 1.31
Reducation of digitalis toxicity by computer-assisted glycoside dosage regimens. Ann Intern Med (1972) 1.30
Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids. Antimicrob Agents Chemother (1999) 1.21
Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg (2001) 1.16
Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest (1997) 1.15
Application of a Bayesian method to monitor and adjust vancomycin dosage regimens. Antimicrob Agents Chemother (1990) 1.13
Pharmacokinetics of ethambutol in children and adults with tuberculosis. Int J Tuberc Lung Dis (2004) 1.11
Clinical studies with computer-assisted initial lidocaine therapy. Arch Intern Med (1984) 1.11
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens. Bone Marrow Transplant (2001) 1.06
Management of postoperative chylothorax. J Visc Surg (2011) 1.05
Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol (1995) 1.01
Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation. Ther Drug Monit (1994) 1.01
Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01
Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method. Clin Pharmacol Ther (1991) 1.01
Hepatic outflow study after piggyback liver transplantation. Surgery (1996) 0.98
Bone loss after orthotopic liver transplantation. Am J Med (1994) 0.97
Mechanical characteristics of fresh and frozen human descending thoracic aorta. J Surg Res (1996) 0.97
Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model. Antimicrob Agents Chemother (1998) 0.96
Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis. Pharmacotherapy (2001) 0.95
An improved method of digitoxin therapy. Ann Intern Med (1970) 0.94
Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids. Pharmacotherapy (1999) 0.92
Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors. Bone Marrow Transplant (2003) 0.92
[Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?]. Chirurgie (1998) 0.91
Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. J Clin Pharm Ther (2006) 0.90
Danazol-induced hepatocellular carcinoma. QJM (2003) 0.90
Serum cardiac glycoside assay based upon displacement of 3 H-ouabain from Na-K ATPase. Circulation (1972) 0.90
Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm. Clin Pharmacokinet (1992) 0.90
Transjugular intra-hepatic portosystemic shunt for refractory variceal bleeding. Eur J Gastroenterol Hepatol (2001) 0.89
Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus. Cancer (2000) 0.89
Long-term results of liver transplantation for Wilson's disease. Gastroenterol Clin Biol (2008) 0.88
Estimation of creatinine clearance from changing serum-creatinine levels. Lancet (1971) 0.88
Factors to consider in planning digoxin therapy. J Chronic Dis (1971) 0.87
Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol (2001) 0.86
Histological benefit of retreatment by pegylated interferon alfa-2b and ribavirin in patients with recurrent hepatitis C virus infection posttransplantation. Am J Transplant (2006) 0.86
Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers. J Hepatol (1998) 0.86
[Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation]. Ann Chir (1998) 0.86
Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage. J Clin Pharm Ther (2004) 0.86
Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors. HPB (Oxford) (2006) 0.86
The USC*PACK PC programs for population pharmacokinetic modeling, modeling of large kinetic/dynamic systems, and adaptive control of drug dosage regimens. Proc Annu Symp Comput Appl Med Care (1991) 0.86
[Intussusception of the small intestine due to Peutz-Jeghers syndrome: a case report and review of the literature]. Ann Chir (2002) 0.85
Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis. Clin Pharm (1987) 0.85
[Laparoscopic pancreatic resections]. Ann Chir (2003) 0.85
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration. Antimicrob Agents Chemother (2000) 0.85
Chorioretinitis following liver transplantation: detection of Toxoplasma gondii in aqueous humor. Clin Infect Dis (1996) 0.84
Functional results of delayed coloanal anastomosis after preoperative radiotherapy for lower third rectal cancer. J Am Coll Surg (2000) 0.84
Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation. J Hepatol (1998) 0.83
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors. Bone Marrow Transplant (2003) 0.83
[Hepatic artery aneurysms]. Ann Chir (2001) 0.83
Erythromycin as a prokinetic agent: risk factors. J Visc Surg (2010) 0.83
Death from weight-control pills. A case report with objective postmortem confirmation. JAMA (1969) 0.83
[A case of hepatic and splenic peliosis occurring in the puerperium after normal pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (1986) 0.82
Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis. J Antimicrob Chemother (2002) 0.82
[Diffuse biliary papillomatosis: a rare indication for liver transplantation]. Gastroenterol Clin Biol (2008) 0.82
Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation. Eur J Clin Pharmacol (2001) 0.81
[Proximal bronchial cancer with hypoxemia due to right to left intrapulmonary shunt. Correction of hypoxemia after pneumonectomy]. Rev Mal Respir (1994) 0.81
How many patients and blood levels are necessary for population pharmacokinetic analysis? A study of a one compartment model applied to cyclosporine. Eur J Clin Pharmacol (1996) 0.81
Computer-controlled administration of cardiovascular drugs. Prog Cardiovasc Dis (1983) 0.81
Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics. Transpl Int (1998) 0.81
Adaptive control of therapeutic drug regimens relations between clinical situations: outcomes and simulations using nonlinear dynamic models. Medinfo (1995) 0.81
[Duodenogastric and gastroesophageal bile reflux]. J Chir (Paris) (2007) 0.80
Open-loop-feedback control of serum drug concentrations: pharmacokinetic approaches to drug therapy. Med Instrum (1983) 0.80
[Fulminant and subfulminant hepatitis treated by orthotopic transplantation of the liver. Apropos of 10 cases]. Chirurgie (1989) 0.80
Correction of acute liver cell failure disorders through liver xenoperfusion: experimental study. Transplant Proc (1997) 0.80
[Use of the French medico-administrative database (PMSI) to detect nosocomial infections in the University hospital of Lyon]. Rev Epidemiol Sante Publique (2011) 0.80
Laparoscopic resection of a proximal splenic artery aneurysm. Surg Endosc (2000) 0.80